Activation of protease-activated receptor-1 triggers astrogliosis after brain injury

J Neurosci. 2005 Apr 27;25(17):4319-29. doi: 10.1523/JNEUROSCI.5200-04.2005.

Abstract

We have studied the involvement of the thrombin receptor [protease-activated receptor-1 (PAR-1)] in astrogliosis, because extravasation of PAR-1 activators, such as thrombin, into brain parenchyma can occur after blood-brain barrier breakdown in a number of CNS disorders. PAR1-/- animals show a reduced astrocytic response to cortical stab wound, suggesting that PAR-1 activation plays a key role in astrogliosis associated with glial scar formation after brain injury. This interpretation is supported by the finding that the selective activation of PAR-1 in vivo induces astrogliosis. The mechanisms by which PAR-1 stimulates glial proliferation appear to be related to the ability of PAR-1 receptor signaling to induce sustained extracellular receptor kinase (ERK) activation. In contrast to the transient activation of ERK by cytokines and growth factors, PAR-1 stimulation induces a sustained ERK activation through its coupling to multiple G-protein-linked signaling pathways, including Rho kinase. This sustained ERK activation appears to regulate astrocytic cyclin D1 levels and astrocyte proliferation in vitro and in vivo. We propose that this PAR-1-mediated mechanism underlying astrocyte proliferation will operate whenever there is sufficient injury-induced blood-brain barrier breakdown to allow extravasation of PAR-1 activators.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amides / pharmacology
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Astrocytes / pathology*
  • Blotting, Northern / methods
  • Blotting, Western / methods
  • Brain Injuries / pathology*
  • Brain Injuries / physiopathology
  • Bromodeoxyuridine / metabolism
  • Butadienes / pharmacology
  • Cell Count / methods
  • Cell Movement / physiology
  • Cell Proliferation
  • Cells, Cultured
  • Coculture Techniques / methods
  • Colforsin / pharmacology
  • Cyclin D1 / metabolism
  • Disease Models, Animal
  • Drug Interactions
  • Enzyme Inhibitors / pharmacology
  • Functional Laterality
  • Glial Fibrillary Acidic Protein / metabolism
  • Gliosis / etiology*
  • Immunohistochemistry / methods
  • MAP Kinase Kinase Kinases / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Microglia / pathology
  • Nitriles / pharmacology
  • Oligopeptides / pharmacology
  • Pyridines / pharmacology
  • RNA, Messenger / biosynthesis
  • Receptor, PAR-1 / deficiency
  • Receptor, PAR-1 / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Thrombin / pharmacology
  • Time Factors

Substances

  • Amides
  • Butadienes
  • Enzyme Inhibitors
  • Glial Fibrillary Acidic Protein
  • Nitriles
  • Oligopeptides
  • PAR-1-activating peptide
  • Pyridines
  • RNA, Messenger
  • Receptor, PAR-1
  • U 0126
  • Cyclin D1
  • Y 27632
  • Colforsin
  • MAP Kinase Kinase Kinases
  • Thrombin
  • Bromodeoxyuridine